Eterna Therapeutics Inc On March 19, Received A Notice From Nasdaq Stating That Co Is Not In Compliance With Nasdaq Listing Rule 5550(B)(1)
Eterna Therapeutics Inc於3月19日收到納斯達克的通知,稱該公司不遵守納斯達克上市規則5550 (B) (1)
Eterna Therapeutics Inc On March 19, Received A Notice From Nasdaq Stating That Co Is Not In Compliance With Nasdaq Listing Rule 5550(B)(1)
Eterna Therapeutics Inc於3月19日收到納斯達克的通知,稱該公司不遵守納斯達克上市規則5550 (B) (1)
使用瀏覽器的分享功能,分享給你的好友吧